As of 2025-05-21, the EV/EBITDA ratio of Brooks Laboratories Ltd (BROOKS.NS) is 86.61. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BROOKS.NS's latest enterprise value is 4,065.32 mil INR. BROOKS.NS's TTM EBITDA according to its financial statements is 46.94 mil INR. Dividing these 2 quantities gives us the above BROOKS.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 15.4x | 11.8x |
| Forward P/E multiples | 13.7x - 22.1x | 17.3x |
| Fair Price | 13.70 - 95.02 | 44.70 |
| Upside | -89.8% - -29.6% | -66.9% |
| Date | EV/EBITDA |
| 2025-05-16 | 88.30 |
| 2025-05-15 | 86.58 |
| 2025-05-14 | 85.73 |
| 2025-05-13 | 87.41 |
| 2025-05-12 | 84.72 |
| 2025-05-09 | 84.10 |
| 2025-05-08 | 81.70 |
| 2025-05-07 | 82.84 |
| 2025-05-06 | 85.35 |
| 2025-05-05 | 85.19 |
| 2025-05-02 | 85.35 |
| 2025-04-30 | 85.04 |
| 2025-04-29 | 85.97 |
| 2025-04-28 | 88.98 |
| 2025-04-25 | 89.64 |
| 2025-04-24 | 94.14 |
| 2025-04-23 | 90.09 |
| 2025-04-22 | 86.92 |
| 2025-04-21 | 86.61 |
| 2025-04-17 | 89.79 |
| 2025-04-16 | 91.47 |
| 2025-04-15 | 89.74 |
| 2025-04-11 | 85.18 |
| 2025-04-09 | 80.33 |
| 2025-04-08 | 78.81 |
| 2025-04-07 | 72.21 |
| 2025-04-04 | 75.94 |
| 2025-04-03 | 81.31 |
| 2025-04-02 | 81.84 |
| 2025-04-01 | 70.92 |
| 2025-03-28 | 68.03 |
| 2025-03-27 | 72.17 |
| 2025-03-26 | 71.49 |
| 2025-03-25 | 70.92 |
| 2025-03-24 | 80.83 |
| 2025-03-21 | 79.33 |
| 2025-03-20 | 75.00 |
| 2025-03-19 | 78.60 |
| 2025-03-18 | 65.90 |
| 2025-03-17 | 63.70 |
| 2025-03-13 | 66.40 |
| 2025-03-12 | 65.93 |
| 2025-03-11 | 67.94 |
| 2025-03-10 | 69.47 |
| 2025-03-07 | 73.92 |
| 2025-03-06 | 73.43 |
| 2025-03-05 | 73.43 |
| 2025-03-04 | 66.91 |
| 2025-03-03 | 68.41 |
| 2025-02-28 | 64.95 |